蛋白质组成决定了HDL在转基因小鼠中的抗atherogenic特性
J R Schultz1, J G Verstuyft, E L Gong
1Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
Nature
|October 21, 1993
概括
高密度脂蛋白 (HDL) 组成影响动脉样硬化. 研究表明,阿波利波蛋白A-I (AI) -HDL对动脉样硬化比阿波利波蛋白A-I和A-II (AI/AII) -HDL更有保护作用.
科学领域:
- 心血管生物学 心血管生物学
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 高密度脂蛋白 (HDL) 在脂质运输和心血管健康方面至关重要.
- 高密度胆固醇包括主要蛋白质阿波利波蛋白A-I (apoA-I) 和阿波利波蛋白A-II (apoA-II).
- 存在两种主要的HDL形式:AI/AII-HDL和AI-HDL,与动脉样硬化有相互矛盾的关联.
研究的目的:
- 研究AI-HDL和AI/AII-HDL对动脉动脉生成的差异性影响.
- 为了确定HDL蛋白质的组成是否影响其抗原性质.
主要方法:
- 人类apoA-I (AI) 和人类apoA-I和apoA-II (AI/AII) 转基因小鼠的生成.
- 进行动脉质饮食以评估病变的发展.
- 在AI和AI/AII小鼠之间比较动脉动脉损伤区域.
主要成果:
- 尽管总胆固醇和高密度胆固醇水平相似,但AI/AII小鼠的动脉动脉损伤面积比AI小鼠大15倍.
- 这表明,基于高密度胆固醇蛋白质组成,在胆固醇生成中存在显著差异.
结论:
- 高密度胆固醇蛋白质的组成极大地影响其在动脉动脉生成中的作用.
- 与AI/AII-HDL相比,AI-HDL表现出更强大的抗原效应.
相关概念视频
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...